Article (Published version) (386 Kb) - Limited access to UNIGE
Other version: http://link.springer.com/10.1007/s10143-016-0797-5
Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?
|Published in||Neurosurgical Review. 2017, vol. 40, no. 1, p. 39-43|
|Abstract||In this review, the authors perform a database search and summarize and discuss all eligible studies that provide (subgroup) analysis of the postoperative seizure outcome of patients with cavernoma-related epilepsy undergoing sole lesionectomy or lesionectomy including the hemosiderin rim. Based on the currently available data, the authors conclude that if surgical treatment of cavernoma-related epilepsy is performed, the peri-lesional hemosiderin should be resected. However, cases of eloquent or multiple localization or widespread hemosiderin deposit in which a complete resection is challenging should undergo a specific preoperative work-up.|
|Keywords||Brain/surgery — Epilepsy/surgery — Hemangioma — Cavernous/surgery — Hemosiderin/metabolism — Humans — Postoperative Period — Treatment Outcome|
|Research group||Groupe Schaller Karl Lothard (neurochirurgie) (851)|
|DAMMANN, P., SCHALLER, Karl Lothard, SURE, U. Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?. In: Neurosurgical Review, 2017, vol. 40, n° 1, p. 39-43. https://archive-ouverte.unige.ch/unige:100379|